Korea to toughen rules on vendor audit

Korea's drug watchdog says it plans to stiffen rules on the vendor audit system of a current Good Manufacturing Practice (cGMP) facility that manufactures drug components or finished products as the GMP for pharmaceutical active ingredients is to be implemented from next year.

However, officials from the Korea Food and Drug Administration explain that the grace period will be given to pharma...